Ozempic en Chile: estudio advierte sobre el peligroso "efecto rebote" y pérdida muscular

from Una Nueva Mañana · host Cooperativa

La académica Fanny Petermann-Rocha explicó el impacto de la semaglutida en la población chilena. Aunque efectiva en grupos específicos, su uso sin cambio de hábitos puede dejar al paciente con "solo grasa" al suspenderlo. Conduce Cecilia Rovaretti y Sebastián Esnaola.

Episode metadata supplied by the publisher feed · Published Dec 15, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Ozempic en Chile: estudio advierte sobre el peligroso "efecto rebote" y pérdida muscular

0:00 35:52

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

How Una See Am Podcast Femi and Maazi Dis na Ogbonge pidgin talk talk show wey we dey host ontop podcast to talk about plenty things wey dey affect us as a people and our community. The hosts for dis talk talk show na two brothers, Femi and Maazi.

Frequently Asked Questions

How long is this episode of Una Nueva Mañana?

This episode is 35 minutes long.

When was this Una Nueva Mañana episode published?

This episode was published on December 15, 2025.

Can I download this Una Nueva Mañana episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!